Session information

Oral

[3O04m1] Alzheimer's Disease and Dementia 1

Sat. Jul 2, 2022 9:00 AM - 10:00 AM Room 4 (Conference Building B5~7 (Okinawa Convention Center))

Chair: Tomohiro Umeda

+Add all to schedule

[3O04m1-01] HDAC3 inhibition ameliorates dystrophic axons and memory function via secretion of IGFBP6 from microglia in a transgenic mouse model of Alzheimer's disease

*Tomoharu Kuboyama¹, Hikari Okamoto¹, Chihiro Tohda² (1. Lab of Pharmacognosy, Daiichi Univ of Pharmacy, Fukuoka, Japan, 2. Sec of Neuromedical Science, Inst of Natural Medicine, Univ of Toyama, Toyama, Japan)

[3O04m1-02] Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination

*Tomohiro Umeda¹, Ayumi Sakai¹, Keiko Shigemori¹, Ayumi Yokota¹, Toru Kumagai², Takami Tomiyama^1,2 (1. Grad Sch Med, Osaka City Univ, Osaka, Japan, 2. MedilaboRFP)

[3O04m1-03] miRNAs secreted from choroid plexus plays a critical role for the maintenance of neurogenesis in the aged brain

*Sayako Katada¹, Yusuke Sakaki¹, Kinichi Nakashima¹ (1. Kyushu University)

[3O04m1-04] MTH1 and OGG1 suppress microgliosis, while MUTYH actively contributes to microglial activation and impaired neurogenesis in the pathogenesis of Alzheimer's disease

*Yusaku Nakabeppu¹, Yuri Mizuno^1,2 (1. Med Inst Bioreg, Kyushu Univ, Fukuoka, Japan, 2. Grad Sch Med, Kyushu Univ, Fukuoka, Japan)

Authentication

Abstract password authentication.
A password is required to view the full text of the abstract. Please enter the following password.

PW: Neuro2022

Please log in with your participant account.
» Participant Log In

▲